Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH
VIENNA — AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th Americ
(Financial Post, 2025-12-07T16:02:30Z)